Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)

This study has been withdrawn prior to enrollment.

(No funding for study)

Sponsor:

Information provided by (Responsible Party):

Sophiris Bio Corp

ClinicalTrials.gov Identifier:

NCT00797940

First received: November 24, 2008

Last updated: November 30, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)